Axsome Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Axsome Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 441% to $270,600,000. Profit margin reached -88%. Total operating expenses were $476,360,000.
Profit Margin
| 2014 | 0 | -6.00M | |
|---|---|---|---|
| 2015 | 0 | -10.55M | |
| 2016 | 0 | -27.20M | |
| 2017 | 0 | -28.94M | |
| 2018 | 0 | -30.96M | |
| 2019 | 0 | -69.68M | |
| 2020 | 0 | -105.38M | |
| 2021 | 0 | -134.94M | |
| 2022 | 50.03M | -197.76M | -395.24% |
| 2023 | 270.6M | -239.23M | -88.41% |
AXSM Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 270.6M | 50.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 26.06M | 5.19M | 1.15M | 77.71K | 37.33K | 0 | 42.55K | 0 | 3.54K | 0 |
Gross profit | 244.53M | 44.83M | -1.15M | -77.71K | -37.33K | 0 | -42.55K | 0 | -3.54K | 0 |
Operating exp. | ||||||||||
Research and development | 97.94M | 57.94M | 58.06M | 70.24M | 53.64M | 23.49M | 19.95M | 21.19M | 6.77M | 4.27M |
Selling and marketing | 100.3M | 35.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 476.36M | 221.34M | 124.70M | 99.08M | 67.10M | 32.62M | 26.95M | 27.06M | 9.19M | 5.48M |
Operating income | -231.82M | -176.50M | -124.70M | -99.14M | -67.24M | -32.84M | -27.16M | -27.54M | -9.19M | -5.67M |
Other income (expenses), net | -6.45M | -10.63M | -5.69M | -3.81M | -1.10M | 2.79M | -1.77M | 474.27K | -1.36M | -328.53K |
Income before tax | -238.27M | -187.13M | -130.40M | -102.90M | -68.34M | -30.96M | -28.94M | -27.20M | -10.55M | -6.00M |
Income tax expense | 960K | 10.63M | 4.54M | 2.48M | 1.34M | 3.00M | 1.29M | 586.21K | 1.35M | -2.41M |
Net income | -239.23M | -197.76M | -134.94M | -105.38M | -69.68M | -30.96M | -28.94M | -27.20M | -10.55M | -6.00M |
Earnings per share | ||||||||||
Basic EPS | -5.27 | -4.86 | -3.59 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 |
Diluted EPS | -5.27 | -4.86 | -3.59 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |